Long-term morbidity and mortality among medically managed patients with angina and multivessel coronary artery disease

American Heart Journal

Volumn 158, Issue 6, 2009, Pages 933-940

  Cavender, Matthew A ^a   Alexander, Karen P ^b   Broderick, Samuel ^b   Shaw, Linda K ^b   McCants, Charles B ^b   Kempf, Judith ^a   Ohman, E Magnus ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ANGINA PECTORIS; ARTICLE; CATHETERIZATION; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; FEMALE; HOSPITAL READMISSION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PATIENT SELECTION; POPULATION RESEARCH; PRIORITY JOURNAL; REVASCULARIZATION; THORAX PAIN;

AGED; ANGINA PECTORIS; CORONARY ARTERY DISEASE; FEMALE; HEART CATHETERIZATION; HUMANS; MALE; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 70649094029     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2009.10.013     Document Type: Article

References (23)

1. Rosamond W., Flegal K., Furie K., et al. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117 (2008) e25-e146
2. Gibbons R.J., Abrams J., Chatterjee K., et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol 41 (2003) 159-168
3. Fraker Jr. T.D., Fihn S.D., Gibbons R.J., et al. 2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 guidelines for the management of patients with chronic stable angina. J Am Coll Cardiol 50 (2007) 2264-2274
4. Boden W.E., O'Rourke R.A., Teo K.K., et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 356 (2007) 1503-1516
5. Harris P.J., Lee K.L., Harrell Jr. F.E., et al. Outcome in medically treated coronary artery disease. Ischemic events: nonfatal infarction and death. Circulation 62 (1980) 718-726
6. Mark D.B., Nelson C.L., Califf R.M., et al. Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty. Circulation 89 (1994) 2015-2025
7. Charlson M.E., Pompei P., Ales K.L., et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987) 373-383
8. Boyle C.A., and Decoufle P. National sources of vital status information: extent of coverage and possible selectivity in reporting. Am J Epidemiol 131 (1990) 160-168
9. Bhatt D.L., Peterson E.D., Harrington R.A., et al. Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes. Eur Heart J 30 (2009) 1195-1202
10. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
11. Califf R.M., Harrell Jr. F.E., Lee K.L., et al. The evolution of medical and surgical therapy for coronary artery disease. A 15-year perspective. JAMA 261 (1989) 2077-2086
12. Singh M., Rihal C.S., Gersh B.J., et al. Twenty-five-year trends in in-hospital and long-term outcome after percutaneous coronary intervention: a single-institution experience. Circulation 115 (2007) 2835-2841
13. Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. RITA-2 trial participants. Lancet 350 (1997) 461-468
14. Bucher H.C., Hengstler P., Schindler C., et al. Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: meta-analysis of randomised controlled trials. BMJ 321 (2000) 73-77
15. Hueb W., Soares P.R., Gersh B.J., et al. The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results. J Am Coll Cardiol 43 (2004) 1743-1751
16. Bruschke A.V., Proudfit W.L., and Sones Jr. F.M. Progress study of 590 consecutive nonsurgical cases of coronary disease followed 5-9 years. I. Arterographic correlations. Circulation 47 (1973) 1147-1153
17. Clayton T.C., Lubsen J., Pocock S.J., et al. Risk score for predicting death, myocardial infarction, and stroke in patients with stable angina, based on a large randomised trial cohort of patients. BMJ 331 (2005) 869
18. Smith P.K., Califf R.M., Tuttle R.H., et al. Selection of surgical or percutaneous coronary intervention provides differential longevity benefit. Ann Thorac Surg 82 (2006) 1420-1428 [discussion 1428-9]
19. Antithrombotic Trialists Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324 (2002) 71-86
20. Newby L.K., LaPointe N.M., Chen A.Y., et al. Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation 113 (2006) 203-212
21. Steinberg B.A., Bhatt D.L., Mehta S., et al. Nine-year trends in achievement of risk factor goals in the US and European outpatients with cardiovascular disease. Am Heart J 156 (2008) 719-727
22. Cannon C.P., Braunwald E., McCabe C.H., et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 350 (2004) 1495-1504
23. Fonarow G.C., French W.J., and Frederick P.D. Trends in the use of lipid-lowering medications at discharge in patients with acute myocardial infarction: 1998 to 2006. Am Heart J 157 (2009) 185-194.e2